Tumor stage | CK20 | |||||
Negative | Weak | Moderate | Strong | Total | ||
Stage Ta | N | 6 | 1 | 7 | 11 | 25 |
% | 24.00 | 4.00 | 28.00 | 44.00 | 100.00 | |
Stage T1 | N | 13 | 11 | 39 | 6 | 69 |
% | 18.84 | 15.94 | 56.52 | 8.70 | 100.00 | |
Stage T2 | N | 9 | 7 | 25 | 21 | 62 |
% | 14.52 | 11.29 | 40.32 | 33.87 | 100.00 | |
Stage T3 | N | 4 | 1 | 7 | 14 | 26 |
% | 15.38 | 3.85 | 26.92 | 53.85 | 100.00 | |
stage T4 | N | 0 | 0 | 0 | 5 | 5 |
% | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
Total | N | 32 | 20 | 78 | 57 | 187 |
% | 17.11 | 10.70 | 41.71 | 30.48 | 100.00 | |
Chi-square | X2 | 43.840 | ||||
P-value | 0.000 |